News and Events

Primary tabs

Industry News

2019 Medicines For Europe Legal Affairs Conference

Advertisement: The 2019 Medicines for Europe Legal Affairs Conference will take place, for the first time, in Amsterdam. In its 15th edition, this conference will provide participants with the opportunity to exchange views and share ideas with leading industry executives and experts, counsel and European institution officials around the latest developments in intellectual property and legal affairs concerning generic, biosimilar and value added medicines within Europe and worldwide.

Industry News

Chinese IP Officials Complete Study Of UK, European IP Law

A cohort of senior Chinese officials from the China National Intellectual Property Administration (CNIPA) has graduated from a four-month training programme at the Intellectual Property Research Institute of Queen Mary University of London.

Industry News

Inside Views: Innovation And Regulation Of Gene-Edited Vegetables: An Interview With IP Lawyer Chris Holly

Chris Holly is a practicing intellectual property lawyer with extensive experience helping clients leverage IP portfolios in the agriculture, food, microbiology and biotechnology industries. Intellectual Property Watch's David Branigan interviewed Holly to gain his perspective on the technological, regulatory and intellectual property considerations of next generation plant breeding techniques, in particular those that involve gene editing using CRISPR technology.

Industry News

Inside Views: Will US Drug Pricing Politics Change Intimidation Practices Globally?

Fifa Rahman writes: The global health world, particularly as concerns skyrocketing drug prices and patent abuse, is in a unique space in time. Recently, the Office of the United States Trade Representative (USTR) has been carrying on as per usual. It has threatened the Malaysian and Colombian governments at numerous junctures to prevent them from issuing compulsory licences – a completely legal mechanism which the US uses regularly - to access generic hepatitis C drugs. The Trump Administration has sent delegations to global health agencies in Geneva to intimidate them into reducing, or hiding, work on TRIPS flexibilities and fairer drug pricing.

Industry News

US Perspectives: In US, No Remedies For Growing IP Infringements

Ubi Jus Ibi Remedium. Alas, that longstanding legal principle – where there’s a right, there’s a remedy – doesn’t apply to IP owners in the US. Thanks to several Supreme Court rulings interpreting the US Constitution, owners of patents have no recourse when their IP is infringed by US states. Copyright owners now face the same fate, unless the Supreme Court reverses a recent 4th Circuit decision.

Industry News

USTR Reports On 2018, Lays Out IP Priorities For 2019; China A Main Target

The Office of the United States Trade Representative has issued its annual report on trade relations with other nations, essentially a report on progress and problems from last year and an agenda for what’s coming this year. Multilateral approaches came in for touch criticism, and on intellectual property rights, a vigorous, repeated focus is China.

Industry News

European Patent Office Report Compares Compulsory Licensing Practices By Country

The European Patent Office has published a report detailing differences in the laws and procedures of European countries for the granting of compulsory licences.

Industry News

Rise Of The Machines: Experts Look At AI, Robotics And The Law

<p>NEW YORK -- Artificial intelligence, robots, and the law, are all changing a rapid pace. A panel of experts at a recent event at Fordham Law School discussed latest developments and signs of the limits of the law when applied to AI areas like facial recognition, automated weapons systems, and financial technology. </p>
<p>The post <a rel="nofollow" href="https://www.ip-watch.org/2019/02/27/rise-machines-experts-look-ai-roboti... Of The Machines: Experts Look At AI, Robotics And The Law</a> appeared first on <a rel="nofollow" href="https://www.ip-watch.org">Intellectual Property Watch</a>.</p>

Industry News

Patents Under Debate As Pharma Executives Face US Senate Committee

<p>Executives of seven large pharmaceutical companies faced questioning yesterday from the United States Senate Finance Committee over high drug prices in the US, especially compared with other developed countries. One issue that came under the microscope was patents. </p>
<p>The post <a rel="nofollow" href="https://www.ip-watch.org/2019/02/27/patents-debate-pharma-executives-fac... Under Debate As Pharma Executives Face US Senate Committee</a> appeared first on <a rel="nofollow" href="https://www.ip-watch.org">Intellectual Property Watch</a>.</p>

Industry News

Asian NGOs Raise Concern Over IP And Seeds In RCEP Trade Deal

The Regional Comprehensive Economic Partnership (RCEP) trade agreement under negotiation among Asia and Pacific nations must not include measures that would undercut countries' ability to protect diverse local farming systems and sustainable plant genetic resources for food and agriculture, a range of Asian nongovernmental organisations argue. Groups in India, Malaysia and the Philippines this week specifically called for the RCEP not to include the high-level protections under the International Union for the Protection of New Varieties of Plants (UPOV).

Pages